| Displacement of [3H]DAMGO from human mu opioid receptor - BioAssay Summary 3-Azabicyclo[3.1.0]hexane compounds were designed as novel achiral ## opioid receptor ligands for the treatment of pruritus in dogs. In this paper, we describe the SAR of this class of opioid ligand, highlighting changes to the lead structure which led to compounds having picomolar binding affinity, selective for the ## receptor over ## and ## subtypes. Some subtleties of functional activity will also be described. ..more |
_ | |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target BioActive Compounds: 4 Description: Title: SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives as ## opioid ligands. Abstract: 3-Azabicyclo[3.1.0]hexane compounds were designed as novel achiral ## opioid receptor ligands for the treatment of pruritus in dogs. In this paper, we describe the SAR of this class of opioid ligand, highlighting changes to the lead structure which led to compounds having picomolar binding affinity, selective for the ## receptor over ## and ## subtypes. Some subtleties of functional activity will also be described. (PMID: 22357342) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: Scientific Literature ChEMBL Target ID: 129 ChEMBL target type: Target is a single protein chain Result Definitions
* Activity Concentration. Data Table (Concise) Classification
PageFrom: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||